Technical Analysis for DYN - Dyne Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Reached Overbought | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Volume Surge | Other | 0.57% | |
Pocket Pivot | Bullish Swing Setup | 0.20% | |
180 Bullish Setup | Bullish Swing Setup | 4.63% | |
Pocket Pivot | Bullish Swing Setup | 4.63% | |
Upper Bollinger Band Walk | Strength | 4.63% | |
Slingshot Bullish | Bullish Swing Setup | 4.66% | |
Stochastic Reached Overbought | Strength | 4.66% | |
Upper Bollinger Band Walk | Strength | 4.66% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 10 hours ago |
Up 2% | about 10 hours ago |
Up 1% | about 10 hours ago |
Upper Bollinger Band Resistance | about 10 hours ago |
Down 1% | about 10 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/01/2024
Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The Company utilizes its proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. Dyne is developing a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
Sector: Healthcare
Industry: Biotechnology
Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Oligonucleotide Duchenne Muscular Dystrophy Duchenne Myotonic Dystrophy Genetic Genealogy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Oligonucleotide Duchenne Muscular Dystrophy Duchenne Myotonic Dystrophy Genetic Genealogy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 36.6 |
52 Week Low | 6.4 |
Average Volume | 1,311,927 |
200-Day Moving Average | 19.86 |
50-Day Moving Average | 29.92 |
20-Day Moving Average | 33.17 |
10-Day Moving Average | 34.20 |
Average True Range | 1.80 |
RSI (14) | 61.69 |
ADX | 24.11 |
+DI | 31.68 |
-DI | 16.67 |
Chandelier Exit (Long, 3 ATRs) | 31.21 |
Chandelier Exit (Short, 3 ATRs) | 35.14 |
Upper Bollinger Bands | 36.26 |
Lower Bollinger Band | 30.08 |
Percent B (%b) | 0.88 |
BandWidth | 18.62 |
MACD Line | 1.42 |
MACD Signal Line | 1.33 |
MACD Histogram | 0.088 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 37.45 | ||||
Resistance 3 (R3) | 37.46 | 36.82 | 37.13 | ||
Resistance 2 (R2) | 36.82 | 36.32 | 36.82 | 37.02 | |
Resistance 1 (R1) | 36.16 | 36.01 | 36.49 | 36.14 | 36.91 |
Pivot Point | 35.51 | 35.51 | 35.68 | 35.51 | 35.51 |
Support 1 (S1) | 34.85 | 35.01 | 35.18 | 34.84 | 34.07 |
Support 2 (S2) | 34.20 | 34.70 | 34.20 | 33.96 | |
Support 3 (S3) | 33.54 | 34.20 | 33.85 | ||
Support 4 (S4) | 33.53 |